GCAN — Greater Cannabis Company, Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1695473 ·
Last close
$0.25
Market Cap
$251.1K
52W High
$0.67
52W Low
$0.14
ADV30
4,702
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | 0 | -33,376 | -33,376 | 1,439 | 1,439 | 776,464 |
| Dec 2025 | 0 | 0 | -53,806 | 337,757 | 815 | 815 | 742,464 |
| Sep 2025 | 0 | 0 | -37,412 | -36,099 | 21,355 | 21,355 | 1,129,697 |
| Jun 2025 | 0 | 0 | -48,251 | -390,853 | 26,712 | 26,712 | 1,098,955 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-53,374
Investing CF
$0
Financing CF
$5,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.04
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-5,025,333
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-261,905
Pretax Income TTM
$-122,571
Interest Exp TTM
$-135,966
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -183,005 | -331,612 | 815 | 742,464 | — | -60,153 |
| Dec 2024 | 0 | -156,276 | -179,041 | 57,785 | 898,058 | — | -109,491 |
| Dec 2023 | 0 | -175,364 | -188,402 | 172,276 | 833,508 | — | -103,171 |
| Dec 2022 | 0 | -177,035 | -360,268 | 280,447 | 825,277 | — | -107,490 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VGLS | SB Technology Holdings, Inc. | $232.3K | $0.22 | — |
| CYTOF | Altamira Therapeutics Ltd. | $286.3K | $0.05 | — |
| LIPO | LIPELLA PHARMACEUTICALS INC. | $300.4K | $0.06 | — |
| PTPI | Petros Pharmaceuticals, Inc. | $207.6K | $0.00 | — |
| BNIGF | Beroni Group Ltd | $180.0K | $0.01 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.